Regulatory

Regulatory  ·  Weekly Digest 6
NMPA approved InnoCare’s Orelabrutinib for the treatment of R/R Marginal Zone Lymphoma

Weekly Digest – 15-21 Apr 2023 Weekly Digest – 15-21 Apr 2023 April 19, 2023: Orelabrutinib (Oral) / Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL) / InnoCare: Received NMPA approval in China  Orelabrutinib obtained NMPA approval for treating R/R MZL in […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 6
US FDA approved Roche’s Polivy in combination with R-CHP for DLBCL

Weekly Digest – 15-21 Apr 2023 Weekly Digest – 15-21 Apr 2023 April 19, 2023: Polatuzumab vedotin-piiq (IV) / DLBCL / Roche: Received US FDA approval Roche announced US FDA approval of Polivy® (polatuzumab vedotin-piiq) in combination with Rituxan® (rituximab), […]

by Sandhya Ramalingam

Continue Reading